HIV Medication Adherence in Underserved Populations

Status unconfirmed · Not applicable

Conditions studied: Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome

In brief

The purpose of this study is to determine whether cognitive rehabilitation or psychoeducation impacts medication adherence in HIV-1 seropositive individuals.

Key facts

Study ID

NCT02392884

Run by

Cedars-Sinai Medical Center

People needed

60

Starts

2014-09-01

Expected to finish

2015-12-01

Last updated by the study team

2015-03-19

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult, age 18 and older.
• Able and willing to provide written informed consent.
• Diagnosed as HIV-seropositive by licensed enzyme-linked immunoabsorbent assay (ELISA) or HIV-seropositive by Western blot (WB).
• Diagnosed as HIV seropositive within the last two years.
• Willing and able to provide adequate information for locator purposes.

You may not qualify if…

• Under the age of 18.
• Have ever sustained a traumatic brain injury.
• Have an obvious psychological/psychiatric disorder that would invalidate the informed consent process, or otherwise contraindicate participation in the study.
• Have a learning disability where they cannot read or write pass the third grade level.
• Have an active substance dependence diagnosis.

Where it is running

• Cedars Sinai Medical Center — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.